29 july 2026 Punjab Khabarnama Bureau : For many people with end-stage kidney disease, a kidney transplant offers the best chance of returning to a healthier and more active life. Traditionally, successful transplantation required the donor and recipient to have compatible blood groups (ABO). However, advances in medical science have made ABO-incompatible kidney transplants possible, allowing more patients to receive life-saving organs.
What Is an ABO-Incompatible Kidney Transplant?
An ABO-incompatible (ABOi) kidney transplant is a procedure in which a patient receives a kidney from a donor with a different blood type.
Normally, the recipient’s immune system would recognise the donor kidney as foreign and produce antibodies that could attack the transplanted organ. Modern treatment protocols are designed to reduce or remove these antibodies before surgery, significantly lowering the risk of rejection.
How the Procedure Works
Before transplantation, doctors perform detailed blood tests to measure antibody levels and assess compatibility.
Patients usually undergo specialised treatments such as plasmapheresis (a process that removes harmful antibodies from the blood) and receive medications that suppress the immune system. Additional therapies may be used to reduce the production of antibodies before the transplant takes place.
After surgery, patients continue taking immunosuppressive medicines to help prevent rejection and protect the transplanted kidney.
Who Can Benefit?
ABO-incompatible transplants are particularly useful for patients who have a willing living donor but whose blood groups do not match.
Instead of waiting for a compatible donor, eligible patients may be able to undergo transplantation sooner, reducing the time spent on dialysis and improving long-term health outcomes.
Benefits of the Procedure
Successful ABO-incompatible transplantation can:
- Expand the number of living donor options.
- Reduce waiting times for transplantation.
- Improve quality of life.
- Decrease dependence on long-term dialysis.
- Offer survival rates comparable to compatible living-donor transplants when performed in experienced centres.
Risks and Challenges
Although the procedure has become increasingly successful, it remains more complex than a standard kidney transplant.
Patients require careful monitoring for rejection, infections and medication-related complications. Lifelong follow-up and strict adherence to prescribed treatment remain essential.
A Growing Medical Achievement
Advances in transplant medicine have transformed ABO-incompatible kidney transplantation from a high-risk procedure into a widely accepted option at many specialised hospitals.
For thousands of patients worldwide, it represents a second chance at life by making transplantation possible even when blood groups differ.